Feb 19 (Reuters) - Sonnet Biotherapeutics Holdings Inc SONN.O:
SONNET BIOTHERAPEUTICS ANNOUNCES THAT ITS PROPRIETARY ANTIBODY DRUG CONJUGATE (ADC) PLATFORM IS AVAILABLE FOR DRUG DISCOVERY PARTNERSHIPS WITH POTENTIAL FOR PRODUCING MULTIPLE PIPELINE DRUG CANDIDATES
Source text: [InGNX6BFnLK]
Further company coverage: SONN.O